Dycine Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Noida, Uttar Pradesh, India, established in 2010.
2010 Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Dycine Pharmaceuticals Limited

Dycine Pharmaceuticals Limited, a active public limited company, was established on 30 July 2010 in Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74992UP2010PLC041545. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹26.48 Cr.

It upholds a compliant status. Employing 248 professional, Its leadership includes Rupesh Kumar Gupta (Director), Alok Kumar Singh (Director), Sai Uttam Bahirat Patil (Director). Past directors included Alok Kumar Singh, Sai Uttam Bahirat Patil, Abhishek Agrawal. It holds ₹30.71 Cr open charges and ₹9.50 Cr settled loans. Its latest AGM occurred on 29 November 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No. 381 Block Iii Ganga Shopping Complex, Sector 29, Noida, Uttar Pradesh, 201302.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74992UP2010PLC041545

  • Registration Number

    041545

  • Incorporation Date

    30 July 2010

  • Authorized Capital

    ₹30.00 Cr

  • Paid-Up Capital

    ₹26.48 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 30.00 Cr
  • Paid Up Capital ₹ 26.48 Cr
  • Company Age 15 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 30.71 Cr
  • Satisfied Charges ₹ 9.50 Cr
  • Revenue Growth **** 3.94%
  • Profit Growth **** -38.54%
  • Ebitda **** 24.90%
  • Net Worth 83.08%
  • Total Assets **** 75.41%
Company report

Dycine Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dycine Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dycine Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Rupesh Kumar Gupta Director 30 Jul 2010 Current
Alok Kumar Singh Director 30 Jul 2010 Current
Sai Uttam Bahirat Patil Director 25 Sep 2024 Current
Piyush Kumar Singh Director 30 Jul 2010 Current
Abhishek Agrawal Director 25 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dycine Pharmaceuticals.

Dycine Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.94% increase. The company also saw a substantial fall in profitability, with a 38.54% decrease in profit. The company's net worth Soared by an impressive increase of 83.08%.

Dycine Pharmaceuticals revenue growth over time
Dycine Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.94%
*******
*******
*******
*******
Revenue from Operations
*******
 3.78%
*******
*******
*******
*******
Total Assets
*******
 75.41%
*******
*******
*******
*******
Profit or Loss
*******
 -38.54%
*******
*******
*******
*******
Net Worth
*******
 83.08%
*******
*******
*******
*******
EBITDA
*******
 24.90%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dycine Pharmaceuticals?

In 2024, Dycine Pharmaceuticals had a promoter holding of 83.71% and a public holding of 16.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹307,122,198.00

Satisfied Charges

₹95,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 30.42 Cr
  • Others : 0.29 Cr
Latest Charge Details
Date Lender Amount Status
28 Jan 2022 Hdfc Bank Limited ₹29.37 Cr Open
28 Dec 2021 Hdfc Bank Limited ₹5.94 M Open
02 Nov 2018 Others ₹2.88 M Open
04 Jan 2018 Hdfc Bank Limited ₹1.25 M Open
08 Jun 2017 Hdfc Bank Limited ₹3.30 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Dycine Pharmaceuticals?

Dycine Pharmaceuticals has a workforce of 248 employees as of Jan 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dycine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dycine Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dycine Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dycine Pharmaceuticals Limited last Annual general meeting of members was held on 29 Nov 2025 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Piyush Kumar Singh was appointed as a Cfo was appointed as a Cfo on 28 Apr 2025 & has been associated with this company since 9 months 20 days . was documented.

  • Balance Sheet

    The activity Dycine Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    The activity Sai Uttam Bahirat Patil was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Director Appointment

    Progress on Abhishek Agrawal was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 1 year 4 months . was documented.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 29.37 Cr registered on 28 Jan 2022 with Charge ID 100559499 was modified on 02 Sep 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dycine Pharmaceuticals Limited?

The CIN of Dycine Pharmaceuticals Limited is U74992UP2010PLC041545.

Where is Dycine Pharmaceuticals Limited headquartered?

Dycine Pharmaceuticals Limited is headquartered at Shop No. 381 Block Iii Ganga Shopping Complex, Sector 29, Noida, Uttar Pradesh, 201302.

When was Dycine Pharmaceuticals Limited incorporated?

Dycine Pharmaceuticals Limited was incorporated on 30 July 2010.

Who are the current directors of Dycine Pharmaceuticals Limited?

The current directors of Dycine Pharmaceuticals Limited are

What is the primary industry of Dycine Pharmaceuticals Limited?

The primary industry of Dycine Pharmaceuticals Limited is Trade.

Is Dycine Pharmaceuticals Limited a listed company?

Dycine Pharmaceuticals Limited is unlisted.

What is the capital structure of Dycine Pharmaceuticals Limited?

The authorized capital of Dycine Pharmaceuticals Limited is ₹30.00 Cr, and the paid-up capital is ₹26.48 Cr.

What is the compliance status of Dycine Pharmaceuticals Limited?

The compliance status of Dycine Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available